Last reviewed · How we verify

NCT04264091

Relationship Between Skeletal Muscle Mass and Interventricular Septum Thickness in Apparently Healthy Overweight and Obese Subjects

Completed Last updated 12 February 2020
What this trial tests

trial testing Observational in Obesity in 120 participants. Completed in 1 November 2019.

Timeline
1 January 2019
Primary endpoint
1 October 2019
1 November 2019

Quick facts

Lead sponsorAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
StatusCompleted
Study typeOBSERVATIONAL
Enrollment120
Start date1 January 2019
Primary completion1 October 2019
Estimated completion1 November 2019
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

Who can join

Eligibility, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was aimed at investigating the relationship between skeletal muscle mass and interventricular septum thickness in overweight and obese subjects (BMI≥25)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Observational

Trials testing the same drug.

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04264091.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing